LGALS9 and acute lymphoblastic leukemia: Following this approach, CAR T-cell consolidation at high doses without maintenance therapy is being proposed for at-risk patients Inhibition of Gal-9 represents an unexplored approach that could potentially improve the prognosis of patients with B-ALL and other leukemia subtypes, particularly in the presence of obesity-related factors.